I
Innovia Research Center | Miramar, FL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
ISIS 678354
Olezarsen
Bupropion Hydrochloride
SAR441344
Naltrexone Hydrochloride
SAR441566
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG.
Enrolling
Severe Hypertriglyceridemia
Drug: Olezarsen
A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).
Enrolling
Obesity
Drug: Placebo
Drug: Naltrexone-Bupropion (NB) Combination
This is a multinational, randomized, placebo-controlled, parallel treatment, Phase 2, double-blind, 2 arm study evaluating the efficacy and safety of...
Enrolling
Systemic Lupus Erythematosus
Drug: SAR441344 SC
Drug: Placebo SC
Trial sponsors
C
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems